AGARWALEYE
Dr. Agarwal's Health Care Limited (AGARWALEYE) Stock Analysis
Dr. Agarwal's Health Care Limited operates a network of eye hospitals and vision care services in India. It provides cataract surgery, retina care, LASIK, and optical services across multiple cities. The company is among the prominent listed eye-care chains in India. It is expanding through organic growth and acquisitions.
Healthcare › Medical Instruments & Supplies
₹489.80
-3.66% 1W | +9.90% 52W
Market Cap
15.5k CR
P/E Ratio
105.3
52W High
₹568
52W Low
₹401
Div. Yield
0%
Beta
–
50 DMA
₹502.4
200 DMA
₹470.8
Profit Margin
6.7%
Inst. Own.
27.2%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 333 | 349 | 403 | 417 | 431 | 460 | 487 | 499 | 530 | 564 | 614 |
| Expenses | 244 | 241 | 300 | 310 | 316 | 329 | 360 | 363 | 386 | 403 | 444 |
| Operating Profit | 89 | 108 | 104 | 107 | 115 | 131 | 128 | 136 | 144 | 161 | 170 |
| OPM % | 27% | 31% | 26% | 26% | 27% | 28% | 26% | 27% | 27% | 29% | 28% |
| Other Income | 12 | 20 | 6 | 12 | 13 | 13 | 13 | 8 | 11 | 14 | 6 |
| Interest | 22 | 27 | 27 | 28 | 28 | 25 | 25 | 23 | 21 | 22 | 23 |
| Depreciation | 43 | 47 | 56 | 57 | 58 | 60 | 63 | 68 | 69 | 77 | 78 |
| Profit before tax | 36 | 54 | 27 | 33 | 41 | 59 | 54 | 54 | 65 | 77 | 75 |
| Tax % | 37% | 24% | 33% | 36% | 31% | 27% | 29% | 32% | 33% | 35% | 27% |
| Net Profit | 23 | 41 | 18 | 21 | 28 | 43 | 38 | 36 | 44 | 50 | 55 |
| EPS in Rs | 0.72 | 1.03 | 0.95 | 0.94 | 1.07 | 1.25 | 1.43 |
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 531 | 471 | 696 | 1,018 | 1,332 | 1,711 | 2,080 | 2,207 |
| Expenses | 407 | 387 | 510 | 743 | 965 | 1,248 | 1,503 | 1,595 |
| Operating Profit | 124 | 85 | 186 | 275 | 367 | 463 | 577 | 612 |
| OPM % | 23% | 18% | 27% | 27% | 28% | 27% | 28% | 28% |
| Other Income | 13 | 6 | 17 | 14 | 44 | 43 | 46 | 39 |
| Interest | 54 | 44 | 49 | 76 | 101 | 115 | 98 | 89 |
| Depreciation | 93 | 95 | 98 | 128 | 170 | 231 | 276 | 292 |
| Profit before tax | -11 | -48 | 57 | 84 | 141 | 160 | 249 | 270 |
| Tax % | 82% | 21% | 24% | -24% | 32% | 31% | 32% | |
| Net Profit | -21 | -59 | 43 | 103 | 95 | 110 | 168 | 185 |
| EPS in Rs | 2.64 | 4.20 | 4.69 | |||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 27.0% | 35.0% | – |
| Profit CAGR | 9.0% | 33.0% | – |
Shareholding Pattern
Promoters32.43%
FIIs59.26%
DIIs6.44%
Public1.87%
Promoters32.43%
FIIs58.13%
DIIs7.92%
Public1.52%
Promoters32.39%
FIIs58.06%
DIIs7.78%
Public1.78%
Promoters32.35%
FIIs57.94%
DIIs7.83%
Public1.87%
Promoters32.34%
FIIs57.97%
DIIs7.72%
Public1.97%
Promoters32.45%
FIIs60.62%
DIIs5.21%
Public1.74%
Promoters32.35%
FIIs57.94%
DIIs7.83%
Public1.87%
Promoters32.34%
FIIs57.97%
DIIs7.72%
Public1.97%
AGARWALEYE
Holdings Analysis
Key strengths & risk signals
79
Overall
68
Fundamental
91
Technical
Risks (2)
OVERVALUED! PEG of 9.57 means expensive relative to growth rate.
OVERBOUGHT! RSI at 76.2 - caution, may pull back.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH TREND! 50-day average (474.7) is above 200-day average (470.9) - positive signal.
BREAKOUT! Stock has broken above resistance levels with momentum.
BULLISH SENTIMENT! In last 30 days: 16 up days, 14 down days. Avg volume on up days: 146,326 vs down days: 69,771. Ratio: 2.1x
Fundamental & Technical Analysis
79Overall
68Fundamental
91Technical
Fundamental Breakdown
Growth Quality
26/30
Revenue CAGR: 27.0% (EXCELLENT, 15/15). Profit CAGR: 12.3% (GOOD, 11/15).
Profit Margin
3/10
LOW MARGIN! 6.7% profit margin - thin profits.
PEG Valuation
0/10
OVERVALUED! PEG of 9.57 means expensive relative to growth rate.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
6/10
MODERATE DEBT! D/E of 0.50 - acceptable leverage.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 1.74% public ownership - strong promoter/institutional control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
10/10
BULLISH TREND! 50-day average (474.7) is above 200-day average (470.9) - positive signal.
Price Position
8/10
STRONG POSITION! Current price (546.2) is above both moving averages.
Trend Pattern
20/20
BREAKOUT! Stock has broken above resistance levels with momentum.
52W Performance
8/10
GOOD YEAR! Stock gained 20.3% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 16 up days, 14 down days. Avg volume on up days: 146,326 vs down days: 69,771. Ratio: 2.1x
RSI
2/5
OVERBOUGHT! RSI at 76.2 - caution, may pull back.
52W Range
5/5
STRONG! Trading at 86.9% of 52W range - near yearly highs.
Momentum
5/5
STRONG MOMENTUM! Price has grown across all timeframes - up 14.3% (1 week), 14.3% (1 month), 20.2% (3 months). Momentum is accelerating.
Beta
3/5
MARKET ALIGNED! Beta of 1.00 - moves with the market.
AGARWALEYE
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-08-07 | Concall PDF | |
| Q4FY262026-05-27 | Concall PDF | |
| Q3FY262026-02-10 | Concall PDF | |
| Q2FY262025-11-04 | Concall PDF |
Peer Comparison
Healthcare · Medical Instruments & Supplies · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AGARWALEYE | ₹489.80 | 105.3 | 6.7% | 26.9% | 12.3% | +9.9% | 79 | BREAKDOWN | +50.7% | +13.9% | +26.0% | +8.8% |
| POLYMED | ₹1,705.30 | 54.9 | 15.8% | 19.1% | 22.7% | -11.8% | 75 | BOUNCE FROM SUPPORT | -7.6% | +32.3% | +30.3% | -1.7% |
| TARSONS | ₹341.30 | 164.1 | 2.5% | 14.3% | -43.8% | -0.8% | 62 | CONSOLIDATING UP | -177.8% | -133.3% | +20.6% | -8.9% |
| LAXMIDENTL | ₹195.00 | 34.8 | 10.8% | 19.5% | – | -41.3% | 55 | CONSOLIDATING DOWN | +22.6% | +2.0% | +13.5% | +1.1% |
| LENSKART | ₹683.20 | 178.9 | 6.8% | 35.4% | 67.0% | +75.4% | 72 | APPROACHING RESISTANCE | +269.1% | +10.7% | +43.3% | +7.9% |
| SYNGENE | ₹385.10 | 70 | 6.1% | 5.4% | -12.0% | -43.7% | 54 | BOUNCE FROM SUPPORT | -110.4% | -106.1% | -15.8% | -29.0% |
| MARKSANS | ₹337.50 | 29.6 | 16.3% | 16.7% | 16.2% | +83.7% | 79 | CONSOLIDATING DOWN | +169.6% | +6.1% | +35.6% | -1.8% |
| VIJAYA | ₹1,556.10 | 85.3 | 21.9% | 21.0% | 26.9% | +48.5% | 82 | APPROACHING RESISTANCE | +37.6% | +10.9% | +22.8% | +5.3% |
Data from TradeAlone · Updated daily
